SCHEMBL4851345

SCHEMBL4851345

O=C(O)Cc1nccn1Cc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.56
ALDH1A1 P00352 1/20 0.52
HSP90AB1 P08238 1/20 0.49
HSP90B1 P14625 1/20 0.49
AGTR1 P30556 1/20 0.48
AGTR2 P50052 1/20 0.48
FDPS P14324 1/20 0.48
HDAC1 Q13547 1/20 0.47
POLB P06746 1/20 0.46
HPGD P15428 1/20 0.46
HTT P42858 1/20 0.46
OPRD1 P41143 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
ADRB1 P08588 1/20 0.46
ADRB3 P13945 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9715416 0.98 HSP90AA1 (0.55) HSP90AA1ALDH1A1HSP90AB1HSP90B1AGTR1
SCHEMBL955143 0.86 HSP90AA1 (0.57) HSP90AA1ALDH1A1HSP90AB1HSP90B1AGTR1
SCHEMBL4408950 0.86 HSP90AA1 (0.52) HSP90AA1ALDH1A1HSP90AB1HSP90B1AGTR1
Hydrochloric Acid SCHEMBL1043466 0.86 HSP90AA1 (0.49) HSP90AA1ALDH1A1HSP90AB1HSP90B1AGTR1
Hydrochloric Acid SCHEMBL954438 0.85 HSP90AA1 (0.56) HSP90AA1ALDH1A1HSP90AB1HSP90B1AGTR1
SCHEMBL10621322 0.84 HSP90AA1 (0.60) HSP90AA1ALDH1A1HSP90AB1HSP90B1AGTR1
Hydrochloric Acid SCHEMBL7877038 0.83 HSP90AA1 (0.59) HSP90AA1ALDH1A1HSP90AB1HSP90B1AGTR1
SCHEMBL1051652 0.83 ALDH1A1 (0.54) HSP90AA1ALDH1A1HSP90AB1HSP90B1AGTR1
SCHEMBL21208597 0.82 OPRM1 (0.51) HSP90AA1ALDH1A1HSP90AB1HSP90B1AGTR1
SCHEMBL2872632 0.81 HSP90AA1 (0.56) HSP90AA1ALDH1A1HSP90AB1HSP90B1AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025125302-A1 NOVEL COMPOUNDS GENOME THERAPEUTICS LTD (GB) 2025-06-19 WO disclosed
US-7326788-B2 Selective, potent small molecule protein tyrosine kinase inhibitors; such as 6-chloro-3-(3-methyl-isoxazol-5-yl)-4-(pyridin-4-yl)-1H-quinolin-2-one JANSSEN PHARMACEUTICA N.V. (BE) 2008-02-05 US disclosed
CN-1867334-A Quinolinone derivatives as inhibitors of c-fms kinase JANSSEN PHARMACEUTICA NV (BE) 2006-11-22 CN disclosed
EP-1660087-A2 QUINOLINONE DERIVATIVES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-31 EP disclosed
US-20050049274-A1 Quinolinone derivatives as inhibitors of c-fms kinase JANSSEN PHARMACEUTICA, N.V. (BE) 2005-03-03 US disclosed
WO-2005009967-A2 QUINOLINONE DERIVATIVES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA, N.V. (BE) 2005-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050049274-A1 Quinolinone derivatives as inhibitors of c-fms kinase FLT3, ABL1, FES HSP90AA1 3880/4885ALDH1A1 4098/4885HSP90AB1 3906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.